{
    "thread": {
        "uuid": "f23cc2fe90ce43d9d273b28cdb730528e5e3bbe3",
        "url": "https://www.openpr.com/news/3984767/lucintel-forecasts-the-global-metastatic-colorectal-cancer",
        "site_full": "www.openpr.com",
        "site": "openpr.com",
        "site_section": "https://openpr.com",
        "site_categories": [
            "marketing",
            "financial_news",
            "finance",
            "business"
        ],
        "section_title": "openPR.com - Worldwide Open Public Relations - Publish Press Releases Free of Charge",
        "site_title": "openPR.com - Worldwide Open Public Relations - Publish Press Releases Free of Charge",
        "title": "Lucintel Forecasts the Global Metastatic Colorectal Cancer",
        "title_full": "Lucintel Forecasts the Global Metastatic Colorectal Cancer",
        "published": "2025-04-24T01:17:55.912+03:00",
        "replies_count": 0,
        "participants_count": 1,
        "site_type": "news",
        "country": "US",
        "main_image": "https://cdn.open-pr.com/4/2/423481966_g.jpg",
        "performance_score": 0,
        "domain_rank": 9444,
        "domain_rank_updated": "2025-04-22T00:00:00.000+03:00",
        "licensing_agency": [],
        "social": {
            "facebook": {
                "likes": 0,
                "comments": 0,
                "shares": 0
            },
            "vk": {
                "shares": 0
            }
        }
    },
    "uuid": "f23cc2fe90ce43d9d273b28cdb730528e5e3bbe3",
    "url": "https://www.openpr.com/news/3984767/lucintel-forecasts-the-global-metastatic-colorectal-cancer",
    "ord_in_thread": 0,
    "author": "ABNewswire",
    "published": "2025-04-24T01:17:55.912+03:00",
    "title": "Lucintel Forecasts the Global Metastatic Colorectal Cancer",
    "text": "Lucintel Forecasts the Global Metastatic Colorectal Cancer Market to Reach $12.0 billion by 2030 04-23-2025 11:52 PM CET | Business, Economy, Finances, Banking & Insurance\nPress release from: ABNewswire According to a market report by Lucintel, the future of the global metastatic colorectal cancer market looks promising with opportunities in the hospitals, cancer centers, ambulatory surgical centers, and others markets. The global metastatic colorectal c\nAccording to a market report by Lucintel, the future of the global metastatic colorectal cancer market looks promising with opportunities in the hospitals, cancer centers, ambulatory surgical centers, and others markets. The global metastatic colorectal cancer market is expected to reach an estimated $12.0 billion by 2030\nAccording to a market report by Lucintel, the future of the global metastatic colorectal cancer market [ https://www.lucintel.com/metastatic-colorectal-cancer-market.aspx ] looks promising with opportunities in the hospitals, cancer centers, ambulatory surgical centers, and others markets. The global metastatic colorectal cancer market is expected to reach an estimated $12.0 billion by 2030 from $9.0 billion in 2024, at a CAGR of 4.0% from 2024 to 2030. The major drivers for this market are growing advancement in treatment therapies, increasing awareness around early detection of cancer, and rising incidence of colorectal cancer.\nA more than 150-page report to understand trends, opportunity and forecast in metastatic colorectal cancer market to metastatic colorectal cancer by treatment (chemotherapy, targeted therapies, immunotherapies, monotherapy & combination therapy, and others), drug class (anti-egfr inhibitors, anti-vegf therapies, anti-her2 therapies, immune checkpoint inhibitors, and others), end use (hospitals, cancer centers, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).\nLucintel forecasts that, within the treatment category, chemotherapy will remain the largest segment over the forecast period.\nWithin the end use category, anti-vegf therapies will remain the largest segment.\nDownload sample by clicking on metastatic colorectal cancer market [ https://www.lucintel.com/metastatic-colorectal-cancer-market.aspx ]\nIn terms of region, North America will remain the largest region over the forecast period.\nAmgen, Eli Lilly, Pfizer, Roche Holding AG, Merck Sharp & Dohme, Sanofi, Taiho Oncology, Bristol Myers Squibb, Bayer, Novartis are the major suppliers in the metastatic colorectal cancer market.\nThis unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com [mailto:helpdesk@lucintel.com] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.\nAbout Lucintel\nAt Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.\nContact: Roy Almaguer Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com Tel. +1-972-636-5056\nExplore Our Latest Publications\nSystem Level Test Market\nSmart NIC Market\nSerial (SPI) NOR Flash Market\nHeavy-Duty Connector Market\nIT Connector Market\nNeedle-Free IV Connector Market Market\nRF Coaxial Connector Market\nSpace Grade Connector Market\nUnderwater Connector Market\nWire-to-Board Connector Market Market\nMedia Contact\nCompany Name: Lucintel\nContact Person: Roy Almaguer\nEmail:Send Email [ https://www.abnewswire.com/email_contact_us.php?pr=lucintel-forecasts-the-global-metastatic-colorectal-cancer-market-to-reach-120-billion-by-2030 ]\nPhone: 972.636.5056\nAddress:8951 Cypress Waters Blvd., Suite 160\nCity: Dallas\nState: TEXAS\nCountry: United States\nWebsite: https://www.lucintel.com/\nLegal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com\nThis release was published on openPR.",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
        "Economy, Business and Finance",
        "Health"
    ],
    "topics": [
        "Economy, Business and Finance->financial and economic news",
        "Economy, Business and Finance->business reporting and performance",
        "Economy, Business and Finance->healthcare industry",
        "Health->cancer",
        "Health->health treatment and procedure"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [
        "https://opr.li/com/1c388ae02ab46bf4694fee5667e6a7bd/",
        "https://opr.li/com/cd059e18e0c07757e398e1aea312e5b6/",
        "https://www.abnewswire.com/email_contact_us.php?pr=lucintel-forecasts-the-global-metastatic-colorectal-cancer-market-to-reach-120-billion-by-2030",
        "https://www.lucintel.com/metastatic-colorectal-cancer-market.aspx",
        "https://www.lucintel.com/",
        "https://opr.li/com/868d71020954b37b45f377783d916ed7/",
        "https://opr.li/com/cd059e18e0c07757e398e1aea312e5b6",
        "https://www.abnewswire.com/email_contact_us.php",
        "https://opr.li/com/868d71020954b37b45f377783d916ed7",
        "https://lucintel.com/metastatic-colorectal-cancer-market.aspx",
        "https://lucintel.com/",
        "https://www.opr.li/com/1c388ae02ab46bf4694fee5667e6a7bd/",
        "https://opr.li/com/1c388ae02ab46bf4694fee5667e6a7bd",
        "https://abnewswire.com/email_contact_us.php?pr=lucintel-forecasts-the-global-metastatic-colorectal-cancer-market-to-reach-120-billion-by-2030",
        "https://www.lucintel.com",
        "https://www.opr.li/com/868d71020954b37b45f377783d916ed7/",
        "https://www.opr.li/com/cd059e18e0c07757e398e1aea312e5b6/"
    ],
    "entities": {
        "persons": [],
        "locations": [],
        "organizations": [
            {
                "name": "Ag",
                "sentiment": "none",
                "tickers": [
                    {
                        "ticker": "AG",
                        "exchange": "NYSE"
                    }
                ]
            }
        ]
    },
    "syndication": {
        "syndicated": false,
        "syndicate_id": null,
        "first_syndicated": false
    },
    "trust": {
        "categories": [],
        "bias": null,
        "source": {
            "type": null,
            "city": null,
            "state": null,
            "country": null,
            "domain_type": null,
            "agency": null,
            "organization_name": null
        }
    },
    "rating": null,
    "crawled": "2025-04-24T01:17:55.912+03:00",
    "updated": "2025-04-24T01:17:55.912+03:00"
}